NCT04086914

Brief Summary

This study is comparing the use of a peripheral nerve block and standard opioid pain medications in pain control in hip fractures prior to surgery. A peripheral nerve block is a procedure that injects numbing medicine around a nerve to help decrease the pain, motion, and sensation around the painful site temporarily. The purpose of this study is to evaluate if peripheral nerve blocks are more effective for pain control than just standard opioid pain medication while decreasing the amount of side effects from opioid medication.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Feb 2020

Shorter than P25 for early_phase_1

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 10, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 12, 2019

Completed
5 months until next milestone

Study Start

First participant enrolled

February 1, 2020

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2020

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2020

Completed
Last Updated

September 4, 2024

Status Verified

August 1, 2024

Enrollment Period

9 months

First QC Date

September 10, 2019

Last Update Submit

August 30, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Mean Baseline Pain score on Visual analogue scale at initial encounter

    pain is measured 1-10, 1 being the lowest and 10 being the highest

    0-60 minutes

  • Mean Change from baseline pain score on the visual analogue scale

    pain is measured 1-10, 1 being the lowest and 10 being the highest

    3-8 hours after initial encounter

Study Arms (2)

Non nerve block

NO INTERVENTION

Receives no nerve block

Nerve block

EXPERIMENTAL

Receives nerve block

Procedure: Nerve Block

Interventions

Nerve BlockPROCEDURE

This group will receive a nerve block consisting of 20mL of 5mg/mL ropivicanine and 0.1mL of 10mg'mL dexamethasone.

Nerve block

Eligibility Criteria

Age50 Years - 100 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 50 or older, low energy hip fracture, acute hip fracture

You may not qualify if:

  • On anticoagulants, hardware present near injection site, preexisting nerve injury.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Guay J, Kopp S. Peripheral nerve blocks for hip fractures in adults. Cochrane Database Syst Rev. 2020 Nov 25;11(11):CD001159. doi: 10.1002/14651858.CD001159.pub3.

MeSH Terms

Conditions

Hip Fractures

Interventions

Nerve Block

Condition Hierarchy (Ancestors)

Femoral FracturesFractures, BoneWounds and InjuriesHip InjuriesLeg Injuries

Intervention Hierarchy (Ancestors)

Anesthesia, ConductionAnesthesiaAnesthesia and AnalgesiaDenervationNeurosurgical ProceduresSurgical Procedures, Operative
0

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 10, 2019

First Posted

September 12, 2019

Study Start

February 1, 2020

Primary Completion

November 1, 2020

Study Completion

December 1, 2020

Last Updated

September 4, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share